vs
Kimball Electronics, Inc.（KE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Kimball Electronics, Inc.的季度营收约是Orthofix Medical Inc.的1.6倍（$341.3M vs $219.9M），Kimball Electronics, Inc.净利率更高（1.1% vs -1.0%，领先2.1%），Orthofix Medical Inc.同比增速更快（2.0% vs -4.5%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-11.2M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -10.4%）
金伯尔国际是一家美国企业，旗下拥有金伯尔、国民、Interwoven等多个家具品牌，业务涵盖酒店家具等多元产品线。它的前身是19至20世纪一度成为全球最大钢琴与管风琴制造商的W.W.金伯尔公司，如今转型聚焦商用家具领域发展。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
KE vs OFIX — 直观对比
营收规模更大
KE
是对方的1.6倍
$219.9M
营收增速更快
OFIX
高出6.5%
-4.5%
净利率更高
KE
高出2.1%
-1.0%
自由现金流更多
OFIX
多$28.1M
$-11.2M
两年增速更快
OFIX
近两年复合增速
-10.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $341.3M | $219.9M |
| 净利润 | $3.6M | $-2.2M |
| 毛利率 | 8.2% | 71.1% |
| 营业利润率 | 3.2% | 0.2% |
| 净利率 | 1.1% | -1.0% |
| 营收同比 | -4.5% | 2.0% |
| 净利润同比 | 6.0% | 92.4% |
| 每股收益（稀释后） | $0.15 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KEOFIX
| Q4 25 | $341.3M | $219.9M | ||
| Q3 25 | $365.6M | $205.6M | ||
| Q2 25 | $380.5M | $203.1M | ||
| Q1 25 | $374.6M | $193.6M | ||
| Q4 24 | $357.4M | $215.7M | ||
| Q3 24 | $374.3M | $196.6M | ||
| Q2 24 | $430.2M | $198.6M | ||
| Q1 24 | $425.0M | $188.6M |
净利润KEOFIX
| Q4 25 | $3.6M | $-2.2M | ||
| Q3 25 | $10.1M | $-22.8M | ||
| Q2 25 | $6.6M | $-14.1M | ||
| Q1 25 | $3.8M | $-53.1M | ||
| Q4 24 | $3.4M | $-29.1M | ||
| Q3 24 | $3.2M | $-27.4M | ||
| Q2 24 | $7.5M | $-33.4M | ||
| Q1 24 | $-6.1M | $-36.0M |
毛利率KEOFIX
| Q4 25 | 8.2% | 71.1% | ||
| Q3 25 | 7.9% | 72.2% | ||
| Q2 25 | 8.0% | 68.7% | ||
| Q1 25 | 7.2% | 62.8% | ||
| Q4 24 | 6.6% | 69.0% | ||
| Q3 24 | 6.3% | 68.7% | ||
| Q2 24 | 8.5% | 67.8% | ||
| Q1 24 | 7.9% | 67.5% |
营业利润率KEOFIX
| Q4 25 | 3.2% | 0.2% | ||
| Q3 25 | 4.0% | -8.3% | ||
| Q2 25 | 4.3% | -7.9% | ||
| Q1 25 | 3.1% | -25.2% | ||
| Q4 24 | 2.3% | -5.3% | ||
| Q3 24 | 2.4% | -9.6% | ||
| Q2 24 | 4.6% | -12.5% | ||
| Q1 24 | -1.5% | -15.6% |
净利率KEOFIX
| Q4 25 | 1.1% | -1.0% | ||
| Q3 25 | 2.8% | -11.1% | ||
| Q2 25 | 1.7% | -6.9% | ||
| Q1 25 | 1.0% | -27.4% | ||
| Q4 24 | 1.0% | -13.5% | ||
| Q3 24 | 0.8% | -13.9% | ||
| Q2 24 | 1.8% | -16.8% | ||
| Q1 24 | -1.4% | -19.1% |
每股收益（稀释后）KEOFIX
| Q4 25 | $0.15 | $-0.05 | ||
| Q3 25 | $0.40 | $-0.57 | ||
| Q2 25 | $0.27 | $-0.36 | ||
| Q1 25 | $0.15 | $-1.35 | ||
| Q4 24 | $0.14 | $-0.76 | ||
| Q3 24 | $0.12 | $-0.71 | ||
| Q2 24 | $0.29 | $-0.88 | ||
| Q1 24 | $-0.24 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $82.0M |
| 总债务越低越好 | $153.8M | — |
| 股东权益账面价值 | $579.2M | $450.0M |
| 总资产 | $1.1B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资KEOFIX
| Q4 25 | $77.9M | $82.0M | ||
| Q3 25 | $75.7M | $62.9M | ||
| Q2 25 | $88.8M | $65.6M | ||
| Q1 25 | $51.4M | $58.0M | ||
| Q4 24 | $53.9M | $83.2M | ||
| Q3 24 | $76.6M | $30.1M | ||
| Q2 24 | $78.0M | $26.4M | ||
| Q1 24 | $65.2M | $27.0M |
总债务KEOFIX
| Q4 25 | $153.8M | — | ||
| Q3 25 | $137.5M | $157.2M | ||
| Q2 25 | $147.1M | $157.0M | ||
| Q1 25 | $178.3M | $156.9M | ||
| Q4 24 | $204.5M | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | $294.8M | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益KEOFIX
| Q4 25 | $579.2M | $450.0M | ||
| Q3 25 | $577.1M | $442.5M | ||
| Q2 25 | $569.9M | $458.3M | ||
| Q1 25 | $548.1M | $458.3M | ||
| Q4 24 | $537.5M | $503.1M | ||
| Q3 24 | $547.8M | $525.9M | ||
| Q2 24 | $540.5M | $546.0M | ||
| Q1 24 | $539.1M | $570.3M |
总资产KEOFIX
| Q4 25 | $1.1B | $850.6M | ||
| Q3 25 | $1.1B | $832.6M | ||
| Q2 25 | $1.1B | $837.2M | ||
| Q1 25 | $1.1B | $823.1M | ||
| Q4 24 | $1.1B | $893.3M | ||
| Q3 24 | $1.1B | $867.9M | ||
| Q2 24 | $1.2B | $882.0M | ||
| Q1 24 | $1.3B | $906.0M |
负债/权益比KEOFIX
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.24× | 0.36× | ||
| Q2 25 | 0.26× | 0.34× | ||
| Q1 25 | 0.33× | 0.34× | ||
| Q4 24 | 0.38× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | 0.55× | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-11.2M | $16.8M |
| 自由现金流率自由现金流/营收 | -3.3% | 7.6% |
| 资本支出强度资本支出/营收 | 5.3% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.89× | — |
| 过去12个月自由现金流最近4个季度 | $81.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流KEOFIX
| Q4 25 | $6.9M | $27.7M | ||
| Q3 25 | $8.1M | $12.4M | ||
| Q2 25 | $78.1M | $11.6M | ||
| Q1 25 | $30.9M | $-18.4M | ||
| Q4 24 | $29.5M | $23.7M | ||
| Q3 24 | $45.5M | $11.7M | ||
| Q2 24 | $48.5M | $9.0M | ||
| Q1 24 | $42.6M | $-18.6M |
自由现金流KEOFIX
| Q4 25 | $-11.2M | $16.8M | ||
| Q3 25 | $-2.5M | $2.5M | ||
| Q2 25 | $68.4M | $4.5M | ||
| Q1 25 | $27.0M | $-25.1M | ||
| Q4 24 | $23.1M | $15.2M | ||
| Q3 24 | $32.1M | $6.3M | ||
| Q2 24 | $39.5M | $-360.0K | ||
| Q1 24 | $30.0M | $-29.1M |
自由现金流率KEOFIX
| Q4 25 | -3.3% | 7.6% | ||
| Q3 25 | -0.7% | 1.2% | ||
| Q2 25 | 18.0% | 2.2% | ||
| Q1 25 | 7.2% | -13.0% | ||
| Q4 24 | 6.5% | 7.0% | ||
| Q3 24 | 8.6% | 3.2% | ||
| Q2 24 | 9.2% | -0.2% | ||
| Q1 24 | 7.1% | -15.4% |
资本支出强度KEOFIX
| Q4 25 | 5.3% | 4.9% | ||
| Q3 25 | 2.9% | 4.8% | ||
| Q2 25 | 2.5% | 3.5% | ||
| Q1 25 | 1.0% | 3.5% | ||
| Q4 24 | 1.8% | 4.0% | ||
| Q3 24 | 3.6% | 2.7% | ||
| Q2 24 | 2.1% | 4.7% | ||
| Q1 24 | 3.0% | 5.6% |
现金转化率KEOFIX
| Q4 25 | 1.89× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 11.86× | — | ||
| Q1 25 | 8.11× | — | ||
| Q4 24 | 8.58× | — | ||
| Q3 24 | 14.42× | — | ||
| Q2 24 | 6.43× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KE
| Automotive | $162.3M | 48% |
| Medical | $96.3M | 28% |
| Industrial | $82.7M | 24% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
